Clinical trial

Neoadjuvant GW572016 to Treat Breast Cancer

NCT00206427

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-08-01

PhasePHASE2

Study timeline

Study start (unknown)2004-08-01Date precision: month

Registry last updated2021-09-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

GW572016DRUG

lapatinibDRUG · verified · RxNorm: lapatinib

Sponsors & collaborators

Baylor Breast Care Centerlead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

HoustonTexas, United States1 Los AngelesCalifornia, United States1 AlbuquerqueNew Mexico, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00206427 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.